These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 9187965

  • 21. Increases in 5-lipoxygenase activating protein expression account for enhanced capacity for 5-lipoxygenase metabolism that accompanies differentiation of peripheral blood monocytes into alveolar macrophages.
    Coffey MJ, Wilcoxen SE, Peters-Golden M.
    Am J Respir Cell Mol Biol; 1994 Aug; 11(2):153-8. PubMed ID: 8049076
    [Abstract] [Full Text] [Related]

  • 22. 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension.
    Wright L, Tuder RM, Wang J, Cool CD, Lepley RA, Voelkel NF.
    Am J Respir Crit Care Med; 1998 Jan; 157(1):219-29. PubMed ID: 9445303
    [Abstract] [Full Text] [Related]

  • 23. 5-lipoxygenase-activating protein is an arachidonate binding protein.
    Mancini JA, Abramovitz M, Cox ME, Wong E, Charleson S, Perrier H, Wang Z, Prasit P, Vickers PJ.
    FEBS Lett; 1993 Mar 08; 318(3):277-81. PubMed ID: 8440384
    [Abstract] [Full Text] [Related]

  • 24. A23187-induced translocation of 5-lipoxygenase in osteosarcoma cells.
    Kargman S, Vickers PJ, Evans JF.
    J Cell Biol; 1992 Dec 08; 119(6):1701-9. PubMed ID: 1469057
    [Abstract] [Full Text] [Related]

  • 25. The 5-lipoxygenase pathway regulates vasculogenesis in differentiating mouse embryonic stem cells.
    Finkensieper A, Kieser S, Bekhite MM, Richter M, Mueller JP, Graebner R, Figulla HR, Sauer H, Wartenberg M.
    Cardiovasc Res; 2010 Apr 01; 86(1):37-44. PubMed ID: 19965960
    [Abstract] [Full Text] [Related]

  • 26. Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells.
    Riddick CA, Ring WL, Baker JR, Hodulik CR, Bigby TD.
    Eur J Biochem; 1997 May 15; 246(1):112-8. PubMed ID: 9210472
    [Abstract] [Full Text] [Related]

  • 27. Differential synthesis of 5-lipoxygenase in peripheral blood and synovial fluid neutrophils in rheumatoid arthritis.
    Jobin C, Kreis C, Gauthier J, Letarte J, Beaulieu AD.
    J Immunol; 1991 Apr 15; 146(8):2701-7. PubMed ID: 2016523
    [Abstract] [Full Text] [Related]

  • 28. Primary cultures of rat cerebellar granule cells as a model to study neuronal 5-lipoxygenase and FLAP gene expression.
    Manev H, Uz T.
    Ann N Y Acad Sci; 1999 Apr 15; 890():183-90. PubMed ID: 10668425
    [Abstract] [Full Text] [Related]

  • 29. Localization of 5-lipoxygenase to the nucleus of unstimulated rat basophilic leukemia cells.
    Brock TG, Paine R, Peters-Golden M.
    J Biol Chem; 1994 Sep 02; 269(35):22059-66. PubMed ID: 8071328
    [Abstract] [Full Text] [Related]

  • 30. The 5-lipoxygenase pathway in cultured human intestinal epithelial cells.
    Cortese JF, Spannhake EW, Eisinger W, Potter JJ, Yang VW.
    Prostaglandins; 1995 Mar 02; 49(3):155-66. PubMed ID: 7652184
    [Abstract] [Full Text] [Related]

  • 31. Functional analysis of 5-lipoxygenase promoter repeat variants.
    Vikman S, Brena RM, Armstrong P, Hartiala J, Stephensen CB, Allayee H.
    Hum Mol Genet; 2009 Dec 01; 18(23):4521-9. PubMed ID: 19717473
    [Abstract] [Full Text] [Related]

  • 32. Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors.
    Hattar K, Fink L, Fietzner K, Himmel B, Grimminger F, Seeger W, Sibelius U.
    J Immunol; 2001 May 15; 166(10):6287-93. PubMed ID: 11342652
    [Abstract] [Full Text] [Related]

  • 33. Characterization of the interaction of human 5-lipoxygenase with its activating protein FLAP.
    Häfner AK, Gerstmeier J, Hörnig M, George S, Ball AK, Schröder M, Garscha U, Werz O, Steinhilber D.
    Biochim Biophys Acta; 2015 Nov 15; 1851(11):1465-72. PubMed ID: 26327594
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.
    Voelkel NF, Tuder RM, Wade K, Höper M, Lepley RA, Goulet JL, Koller BH, Fitzpatrick F.
    J Clin Invest; 1996 Jun 01; 97(11):2491-8. PubMed ID: 8647941
    [Abstract] [Full Text] [Related]

  • 35. An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesis.
    Gerstmeier J, Weinigel C, Barz D, Werz O, Garscha U.
    Biochim Biophys Acta; 2014 Sep 01; 1840(9):2961-9. PubMed ID: 24905297
    [Abstract] [Full Text] [Related]

  • 36. BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly.
    Garscha U, Voelker S, Pace S, Gerstmeier J, Emini B, Liening S, Rossi A, Weinigel C, Rummler S, Schubert US, Scriba GK, Çelikoğlu E, Çalışkan B, Banoglu E, Sautebin L, Werz O.
    Biochem Pharmacol; 2016 Nov 01; 119():17-26. PubMed ID: 27592027
    [Abstract] [Full Text] [Related]

  • 37. Lipoxygenase metabolism is required for interleukin-3 dependent proliferation and cell cycle progression of the human M-07e cell line.
    Miller AM, Allen BS, Ziboh V.
    J Cell Physiol; 1997 Mar 01; 170(3):309-15. PubMed ID: 9066788
    [Abstract] [Full Text] [Related]

  • 38. Time-resolved in situ assembly of the leukotriene-synthetic 5-lipoxygenase/5-lipoxygenase-activating protein complex in blood leukocytes.
    Gerstmeier J, Weinigel C, Rummler S, Rådmark O, Werz O, Garscha U.
    FASEB J; 2016 Jan 01; 30(1):276-85. PubMed ID: 26396238
    [Abstract] [Full Text] [Related]

  • 39. Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors.
    Lee E, Lindo T, Jackson N, Meng-Choong L, Reynolds P, Hill A, Haswell M, Jackson S, Kilfeather S.
    Am J Respir Crit Care Med; 1999 Dec 01; 160(6):2079-85. PubMed ID: 10588632
    [Abstract] [Full Text] [Related]

  • 40. Differential regulation of cyclo-oxygenase-2 and 5-lipoxygenase-activating protein (FLAP) expression by glucocorticoids in monocytic cells.
    Goppelt-Struebe M, Schaefer D, Habenicht AJ.
    Br J Pharmacol; 1997 Oct 01; 122(4):619-24. PubMed ID: 9375956
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.